В статье представлены результаты клинико-генетического исследования полиморфизма генов ренин-ангиотензин-альдостероновой системы при различных типах ремоделирования левого желудочка у пациентов с эссенциальной артериальной гипертензией.

1. Wang H, Wang S, Yi X, Tao Y, Qian H, Jia P, Chen Y, Sun Y. Estimate of ischemic stroke prevalence according to a novel 4-tiered classification of left ventricular hypertrophy: insights from the general Chinese population. Ann Med. 2018 Sep; 50(6):519– 528.

2. Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006 Apr 1;97(7):959– 63.

3. Vakili B A, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 2001; 141(3): 334– 341.

4. Garg S, de Lemos JA, Ayers C, Khouri MG, Pandey A, Berry J D, Peshock RM, Drazner and MH. Association of a 4-tiered classification of left ventricular hypertrophy with adverse cardiovascular outcomes in the general population. JACC Cardiovasc Imaging. 2015 September; 8(9): 1034–1041.

5. Шляхто ЕВ, Конради АО. Ремоделирование сердца при гипертонической болезни – патогенетические факторы и прогностическое значение. Кардиология СНГ. 2003;1(1); 20–32.

6. Nwabuo CC, Vasan RS. Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy. Curr Hypertens Rep. 2020 Feb 3;22(2):11.

7. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. J Am Coll Cardiol. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. 1992 Jun;19(7):1550– 8.

8. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018; 39(33):3021–3104.

9. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):577– 605.

10. Garner C [et al.]. Genetic and environmental influences on left ventricular mass. A family study. Hypertension. 2000 Nov; 36(5);740–746.

11. Post WS [et al.]. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997 Nov; 30(5):1025–1028.

12. Network DK Arnett [et al.]. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Am. J. Hypertens. 2001 Dec; 14(12):1226–1230.

13. Bella JN, MacCluer JW, Roman MJ, Almasy L, North KE, Best LG, Lee ET, Fabsitz RR, Howard BV, Devereux RB. Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study. J Hypertens. 2004 Feb; 22(2):281–6.

14. Lam C., Liu X., Yang Q., Larson M. G., Pencina M. J., Jayashri Aragam J., Redfield M., Benjamin E. J. and Vasan R. S. Familial Aggregation of Left Ventricular Geometry and Association with Parental Heart Failure: The Framingham Heart Study. Circ Cardiovasc Genet. 2010 December; 3(6): 492–498.

15. Bella J. N. and Harald HH Göring.Genetic epidemiology of left ventricular hypertrophy. Am J Cardiovasc Dis. 2012; 2(4): 267–278.

16. Шляхто ЕВ, Конради АО. Роль генетических факторов в ремоделировании сердечно-сосудистой системы при гипертонической болезни. Артериальная гипертензия. 2002; 4(3): 22–29.

17. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging.2016;17:412.

18. Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. J Hypertens. 2017 Sep;35(9):1727–1741.

19. Casper N. Bang,Gerdts E, Aurigemma GP , Boman K, Giovanni de Simone, Björn Dahlöf, Lars Køber, Wachtell K and Devereux RB. Four-Group Classification of Left Ventricular Hypertrophy Based on Ventricular Concentricity and Dilatation Identifies a Low-Risk Subset of Eccentric Hypertrophy in Hypertensive Patients. Circulation: Cardiovascular Imaging.2014;7:422–429.

20. Кузнецова ТЮ. Клинико-генетические факторы предрасположенности к артериальной гипертензии и поражению органов-мишеней. Автореф. докт.диссерт. Петрозаводск. 2009; 42.

21. Конради АО. Ремоделирование сердца и крупных сосудов при гипертонической болезни. Автореф. докт.диссерт. Санкт-Петербург. 2003; 31.

22. Jeunemaitre X. Genetics of the human rennin angiotensin system. J Mol Med 2008; 86: 637–41.

23. Чистяков ДА, Кобалава ЖД, Терещенко СН, Моисеев СВ, Носиков ВВ. Полиморфизм гена сосудистого рецептора ангиотензина II и сердечно-сосудистые заболевания. Терапевтический архив. 2000; 4: 27–30.

24. Wang X [et al.] Effects of angiotensinogen and angiotensin II type I receptor genes on blood pressure and left ventricular mass trajectories in multiethnic youth. Twin Res Hum Genet. 2006 Jun; 9(3):393–402.

25. Smilde TD, Zuurman MW, Hillege HL, van Veldhuisen DJ, van Gilst WH, van der Steege G, Voors AA, Kors JA, de Jong PE, Navis G. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. Am J Hypertens. 2007 Oct;20(10):1097–103.

26. Jin Y, Kuznetsova T, Thijs L, Schmitz B, Liu Y, Asayama K, Brand SM, Heymans S, Brand E, Fagard R, Staessen JA. Association of left ventricular mass with the AGTR1 A1166C polymorphism. Am J Hypertens. 2012 Apr;25(4):472–8.

27. Li Y, Li X, Jia N et al. Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polymorphism and coronary artery disease in Chinese populations. J RAAS 2013; 14 (1): 82–90.

28. Павлова ОС, Коробко ИЮ, Нечесова ТА и др. Факторы риска прогрессирования сосудистого ремоделирования сонных артерий у пациентов с артериальной гипертензией. Системные гипертензии. 2018; 15 (3): 32–38.

29. Rubattu S, Di Angelantonio E, Stanzione R et al. Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/ AT1 gene variant. J Hypertens. 2004; 22 (11): 2129–34.

30. Miyaki K, Hara A, Araki J, Zhang L, Song Y, Kimura T et al. C3123A polymorphism of the angiotensin II type 2 receptor gene and salt sensitivity in healthy Japanese men. Journal of Human Hypertension. 2006;20:467–469.

31. Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V. Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol. 2001 Jan;37(1):175–82.

32. Christensen K, Murray JC. What genome-wide association studies can do for medicine.N Engl J Med. 2007 Mar 15; 356(11):1094–7.

33. Aoki S, Mukae S, Itoh S, Sato R, Nishio K, Ueda H et al. Genetic back-ground in patients with acute myocardial infarction. Jpn Heart J. 2001;42:15–28.